Last reviewed · How we verify
NCT04672018: CT
Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis
Phase 2 trial testing Houtou Jianweiling tablet in Gastritis in 240 participants. Completed in 2 February 2023.
2 February 2023
Quick facts
| Lead sponsor | University of Karachi |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 8 November 2022 |
| Primary completion | 2 February 2023 |
| Estimated completion | 2 February 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Houtou Jianweiling tablet
- Omeprazole Tablet
Conditions studied
- Gastritis — all drugs for Gastritis →
Sponsor
University of Karachi
Who can join
Adults 18 to 65, any sex, with Gastritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the efficacy \& safety of Houtou Jianweiling tablet through the non-inferiority clinical trial of Houtou Jianweiling tablet with Omeprazole Enteric-coated tablet in patients with chronic non-atrophic gastritis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The safety and efficacy of Houtou Jianweiling tablet in patients with chronic non-atrophic gastritis: a double-blind, non-inferiority, randomized controlled trial.
Shah MR, Fatima S, Khan SN, Shafiullah, et al · · 2024 · cited 1× · PMID 38440179 · DOI 10.3389/fphar.2024.1293272
Verify or expand the search:
- PubMed search for NCT04672018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastritis
Currently open trials in the same condition.
- NCT07032961 — A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening · recruiting
- NCT06948487 — Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis · recruiting
- NCT06848400 — Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios · NA · recruiting
Other University of Karachi trials
Trials by the same sponsor.
- NCT07496099 — Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome · NA · not yet recruiting
- NCT07396233 — Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With · NA · recruiting
- NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
- NCT07205042 — Walking for Hypothyroidism Trial (WHT) · NA · not yet recruiting
- NCT06960330 — Wearable Biofeedback Devices for Remote Physiotherapy and Rehabilitation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04672018 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Karachi
- Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04672018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing